The present study used the TP-induced BPH rat model to investigate the therapeutic effect of EA and we found that EA significantly reduced the prostate size, epithelial thickness, serum DHT levels, and the protein levels of AR, 5AR2, and PSA in the TP-induced BPH rat model. This evidence concerns the gene AR and benign prostatic hyperplasia.